Jane Street
NBRV

Jane Street’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Jane Street’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,656
Closed -$12K – 10987
2022
Q2 		$12K Buy
+2,656
New +$17.3K ﹤0.01% 9285
2022
Q1 		– Sell
-1,249
Closed -$19K – 11535
2021
Q4 		$19K Buy
+1,249
New +$29.6K ﹤0.01% 9818
2021
Q2 		– Sell
-1,882
Closed -$78K – 10877
2021
Q1 		$78K Buy
+1,882
New +$117K ﹤0.01% 8722
2020
Q3 		– Sell
-116
Closed -$19K – 8322
2020
Q2 		$19K Buy
116
+46
+66% +$7.67K ﹤0.01% 6972
2020
Q1 		$10K Buy
+70
New +$21.4K ﹤0.01% 5201
2019
Q1 		– Sell
-79
Closed -$29K – 5929
2018
Q4 		$29K Buy
+79
New +$42.5K ﹤0.01% 4764
2017
Q4 		– Sell
-143
Closed -$293K – 5407
2017
Q3 		$293K Buy
+143
New +$335K ﹤0.01% 3723

Other funds holding NBRV

VFA
Values First Advisors Gray, Tennessee $219M AUM 33.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's NBRV Position: Q3 2022 in Review

Jane Street sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2022, closing a stake of 2,656 shares — an estimated $12K sold.

Jane Street first reported a position in NBRV in Q3 2017 and held it in 7 quarters. The position peaked at $293K in Q3 2017. 13 funds tracked by Wall St. Rank hold NBRV as of Q3 2022.

  • Jane Street reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2022 after selling out during the quarter.
  • Jane Street sold 2,656 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2022, an estimated $12K.
  • Jane Street first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2017 and held it in 7 quarters.
  • Jane Street's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $293K in Q3 2017.
  • 13 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2022.

Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.